-
1
-
-
35148892823
-
European guidelines on cardiovascular disease prevention in clinical practice: fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)
-
Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 28 (2007) 2375-2414
-
(2007)
Eur J Cardiovasc Prev Rehabil
, vol.28
, pp. 2375-2414
-
-
Graham, I.1
Atar, D.2
Borch-Johnsen, K.3
Boysen, G.4
Burell, G.5
Cifkova, R.6
-
2
-
-
42449144309
-
Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida
-
Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. Guías de práctica clínica sobre prevención de la enfermedad cardiovascular: versión resumida. Rev Esp Cardiol 61 (2008) 82.e1-82.e49
-
(2008)
Rev Esp Cardiol
, vol.61
-
-
Graham, I.1
Atar, D.2
Borch-Johnsen, K.3
Boysen, G.4
Burell, G.5
Cifkova, R.6
-
3
-
-
11144328988
-
Nuevas estrategias en prevención cardiovascular
-
Lobos J.M., and Brotons C. Nuevas estrategias en prevención cardiovascular. Aten Primaria 34 (2004) 389-391
-
(2004)
Aten Primaria
, vol.34
, pp. 389-391
-
-
Lobos, J.M.1
Brotons, C.2
-
4
-
-
3442901086
-
Adaptación española de la guía europea de prevención cardiovascular
-
Brotons C., Royo-Bordonada M.A., Álvarez-Sala L., Armario P., Artigao R., Conthe P., et al. Adaptación española de la guía europea de prevención cardiovascular. Rev Esp Salud Pública 78 (2004) 435-438
-
(2004)
Rev Esp Salud Pública
, vol.78
, pp. 435-438
-
-
Brotons, C.1
Royo-Bordonada, M.A.2
Álvarez-Sala, L.3
Armario, P.4
Artigao, R.5
Conthe, P.6
-
5
-
-
8744241613
-
Adaptación española de la guía europea de prevención cardiovascular
-
Brotons C., Royo-Bordonada M.A., Álvarez-Sala L., Armario P., Artigao R., Conthe P., et al. Adaptación española de la guía europea de prevención cardiovascular. Neurología 19 (2004) 438-439
-
(2004)
Neurología
, vol.19
, pp. 438-439
-
-
Brotons, C.1
Royo-Bordonada, M.A.2
Álvarez-Sala, L.3
Armario, P.4
Artigao, R.5
Conthe, P.6
-
6
-
-
67649470868
-
-
Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Madrid: Ministerio de Sanidad y Consumo; 2004.
-
Guía Europea de Prevención Cardiovascular en la Práctica Clínica. Madrid: Ministerio de Sanidad y Consumo; 2004.
-
-
-
-
7
-
-
4344575902
-
Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice
-
De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardio Prev Rev 10 Suppl1 (2003) S1-S78
-
(2003)
Eur J Cardio Prev Rev
, vol.10
, Issue.SUPPL.1
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
Brotons, C.4
Cifkova, R.5
Dallongeville, J.6
-
8
-
-
34250897337
-
Calibración de la tabla SCORE de riesgo cardiovascular para España
-
Sans S., Fitzgerald A.P., Royo D., Conroy R., and Grahan I. Calibración de la tabla SCORE de riesgo cardiovascular para España. Rev Esp Cardiol 60 (2007) 476-485
-
(2007)
Rev Esp Cardiol
, vol.60
, pp. 476-485
-
-
Sans, S.1
Fitzgerald, A.P.2
Royo, D.3
Conroy, R.4
Grahan, I.5
-
9
-
-
67649467815
-
-
Instituto Nacional de Estadística. Defunciones según la Causa de Muerte 2006 Tablas Nacionales. Defunciones por causas (lista reducida), sexo y edad. [Acceso 2008] Disponible en: http://www.ine.es/inebase/cgi/axi
-
Instituto Nacional de Estadística. Defunciones según la Causa de Muerte 2006 Tablas Nacionales. Defunciones por causas (lista reducida), sexo y edad. [Acceso 2008] Disponible en: http://www.ine.es/inebase/cgi/axi
-
-
-
-
11
-
-
34250019702
-
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000
-
Ford E.S., Ajani U.A., Croft J.B., Critchley J.A., Labarthe D.R., Kottke T.E., et al. Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000. N Engl J Med 356 (2007) 2388-2398
-
(2007)
N Engl J Med
, vol.356
, pp. 2388-2398
-
-
Ford, E.S.1
Ajani, U.A.2
Croft, J.B.3
Critchley, J.A.4
Labarthe, D.R.5
Kottke, T.E.6
-
14
-
-
0019794526
-
The strategy of prevention: lessons from cardiovascular disease
-
Rose G. The strategy of prevention: lessons from cardiovascular disease. BMJ 282 (1981) 1847-1851
-
(1981)
BMJ
, vol.282
, pp. 1847-1851
-
-
Rose, G.1
-
15
-
-
0028071980
-
Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension
-
Pyorala K., De Backer G., Graham I., Poole-Wilson P., and Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and the European Society of Hypertension. Atherosclerosis 110 (1994) 121-161
-
(1994)
Atherosclerosis
, vol.110
, pp. 121-161
-
-
Pyorala, K.1
De Backer, G.2
Graham, I.3
Poole-Wilson, P.4
Wood, D.5
-
16
-
-
0032189666
-
Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention
-
Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyorala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on coronary prevention. Eur Heart J 19 (1998) 1434-1503
-
(1998)
Eur Heart J
, vol.19
, pp. 1434-1503
-
-
Wood, D.1
De Backer, G.2
Faergeman, O.3
Graham, I.4
Mancia, G.5
Pyorala, K.6
-
17
-
-
0038579421
-
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
-
SCORE project group
-
Conroy R., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al., SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
-
(2003)
Eur Heart J
, vol.24
, pp. 987-1003
-
-
Conroy, R.1
Pyörälä, K.2
Fitzgerald, A.P.3
Sans, S.4
Menotti, A.5
De Backer, G.6
-
19
-
-
67649461041
-
-
The Health Benefits of Smoking Cessation. Washington: US Department of Health and Human Services; 1990.
-
The Health Benefits of Smoking Cessation. Washington: US Department of Health and Human Services; 1990.
-
-
-
-
20
-
-
34250218747
-
-
Blackwell, Oxford
-
McEwen A., Hajek P., McRobbic H., and West R. Manual of Smoking Cessation (2006), Blackwell, Oxford
-
(2006)
Manual of Smoking Cessation
-
-
McEwen, A.1
Hajek, P.2
McRobbic, H.3
West, R.4
-
21
-
-
0034504237
-
Subcutanuous and visceral adipose tissue: their relation to the metabolic syndrome
-
Wajchenberg B. Subcutanuous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21 (2000) 697-738
-
(2000)
Endocr Rev
, vol.21
, pp. 697-738
-
-
Wajchenberg, B.1
-
22
-
-
0025300496
-
Regional distribution of body fat, plasma lipoprotein, and cardiovascular disease
-
Despres J., Moorjani S., Lupien P.J., Tremblay A., Nadeau A., and Bouchard C. Regional distribution of body fat, plasma lipoprotein, and cardiovascular disease. Arteriosclerosis 10 (1990) 497-511
-
(1990)
Arteriosclerosis
, vol.10
, pp. 497-511
-
-
Despres, J.1
Moorjani, S.2
Lupien, P.J.3
Tremblay, A.4
Nadeau, A.5
Bouchard, C.6
-
23
-
-
0004318660
-
-
World Health Organization Consultation of Obesity, Division of Non-communicable Diseases, Programme of Nutrition, Family and Reproductive Health, WHO, Geneva
-
World Health Organization Consultation of Obesity. Obesity: Preventing and Managing the Global Epidemic (1998), Division of Non-communicable Diseases, Programme of Nutrition, Family and Reproductive Health, WHO, Geneva
-
(1998)
Obesity: Preventing and Managing the Global Epidemic
-
-
-
24
-
-
0032162184
-
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
-
National Heart, Lung, and Blood Institute Obesity Education Initative Expert Panel
-
National Heart, Lung, and Blood Institute Obesity Education Initative Expert Panel. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 6 (1998) S51-S209
-
(1998)
Obes Res
, vol.6
-
-
-
25
-
-
27844461474
-
Effects of physical activity on life expectancy with cardiovascular disease
-
Franco O., De Laet C., Peeters A., Jonker J., Mackenbach J., and Nusselder W. Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 165 (2005) 2355-2360
-
(2005)
Arch Intern Med
, vol.165
, pp. 2355-2360
-
-
Franco, O.1
De Laet, C.2
Peeters, A.3
Jonker, J.4
Mackenbach, J.5
Nusselder, W.6
-
26
-
-
2342589486
-
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials
-
Taylor R., Brown A., Ebrahim S., Jolliffe J., Noorani H., Rees K., et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116 (2004) 682-692
-
(2004)
Am J Med
, vol.116
, pp. 682-692
-
-
Taylor, R.1
Brown, A.2
Ebrahim, S.3
Jolliffe, J.4
Noorani, H.5
Rees, K.6
-
27
-
-
0025234906
-
Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias
-
MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
Collins, R.4
Sorlie, P.5
Neaton, J.6
-
28
-
-
0030003819
-
15-year longitudinal study of blood pressure and dementia
-
Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
-
(1996)
Lancet
, vol.347
, pp. 1141-1145
-
-
Skoog, I.1
Lernfelt, B.2
Landahl, S.3
Palmertz, B.4
Andreasson, L.A.5
Nilsson, L.6
-
29
-
-
0035904776
-
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
-
Vasan R., Larson M.G., Leip E.P., Kannel W.B., and Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358 (2001) 1682-1686
-
(2001)
Lancet
, vol.358
, pp. 1682-1686
-
-
Vasan, R.1
Larson, M.G.2
Leip, E.P.3
Kannel, W.B.4
Levy, D.5
-
30
-
-
34250350040
-
2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hyperten 25 (2007) 1105-1187
-
(2007)
J Hyperten
, vol.25
, pp. 1105-1187
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
-
31
-
-
0035968623
-
Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
-
PROGRESS Collaborative Group
-
PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
-
(2001)
Lancet
, vol.358
, pp. 1033-1041
-
-
-
32
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and micro-HOPE substudy
-
HOPE: Heart Outcomes Prevention Evaluation Study Investigators
-
HOPE: Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and micro-HOPE substudy. Lancet 355 (2000) 253-259
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
33
-
-
28844504752
-
Effects of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis
-
Casas J., Chua W., Loukogeorgakis S., Vallance P., Smeeth L., Hingorani A.R., et al. Effects of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366 (2005) 2026-2033
-
(2005)
Lancet
, vol.366
, pp. 2026-2033
-
-
Casas, J.1
Chua, W.2
Loukogeorgakis, S.3
Vallance, P.4
Smeeth, L.5
Hingorani, A.R.6
-
34
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
-
LIFE Study Group
-
Dahlöf B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., De Faire U., et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359 (2002) 995-1003
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlöf, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
De Faire, U.6
-
35
-
-
29244436688
-
New-onset diabetes and antihypertensive drugs
-
Mancia G., Grassi G., and Zancheti A. New-onset diabetes and antihypertensive drugs. J Hypertens 24 (2006) 3-10
-
(2006)
J Hypertens
, vol.24
, pp. 3-10
-
-
Mancia, G.1
Grassi, G.2
Zancheti, A.3
-
37
-
-
0038581685
-
Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension
-
Office versus Ambulatory Pressure Study Investigators
-
Clement D., De Buyzere M.L., De Bacquer D.A., De Leeuw P.W., Duprez D.A., Fagard R.H., et al., Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. N Engl J Med 348 (2003) 2407-2415
-
(2003)
N Engl J Med
, vol.348
, pp. 2407-2415
-
-
Clement, D.1
De Buyzere, M.L.2
De Bacquer, D.A.3
De Leeuw, P.W.4
Duprez, D.A.5
Fagard, R.H.6
-
38
-
-
17644382219
-
Estudio PREVENCAT: control del riesgo cardiovascular en atención primaria
-
Suárez C., Ruilope L.M., Banegas Banegas J.R., Álvarez-Sala Wather L.A., Franch J., Barrios Alonso V., et al. Estudio PREVENCAT: control del riesgo cardiovascular en atención primaria. Med Clin (Barc) 124 (2005) 406-410
-
(2005)
Med Clin (Barc)
, vol.124
, pp. 406-410
-
-
Suárez, C.1
Ruilope, L.M.2
Banegas Banegas, J.R.3
Álvarez-Sala Wather, L.A.4
Franch, J.5
Barrios Alonso, V.6
-
39
-
-
33745233494
-
Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain
-
Banegas J.R., Guallar-Castillon P., Rodriguez-Artalejo F., Graciani A., Lopez-Garcia E., and Ruilope L.M. Association between awareness, treatment, and control of hypertension, and quality of life among older adults in Spain. Am J Hypertens 19 (2006) 686-693
-
(2006)
Am J Hypertens
, vol.19
, pp. 686-693
-
-
Banegas, J.R.1
Guallar-Castillon, P.2
Rodriguez-Artalejo, F.3
Graciani, A.4
Lopez-Garcia, E.5
Ruilope, L.M.6
-
40
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
Cholesterol Treatment Trialists' (CTT) Collaborators
-
Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al., Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
Blackwell, L.4
Buck, G.5
Pollicino, C.6
-
41
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo controlled trial
-
CARDS investigators
-
Colhoun H., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al., CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo controlled trial. Lancet 364 (2004) 685-696
-
(2004)
Lancet
, vol.364
, pp. 685-696
-
-
Colhoun, H.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
-
42
-
-
26844447541
-
Early and late benefit of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE-IT-TIMI22 trial
-
PROVE IT-TIMI 22 Investigators
-
Ray K., Cannon C.P., McCabe C.H., Cairns R., Tonkin A.M., Sacks F.M., et al., PROVE IT-TIMI 22 Investigators. Early and late benefit of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE-IT-TIMI22 trial. J Am Coll Cardiol 46 (2005) 1405-1410
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1405-1410
-
-
Ray, K.1
Cannon, C.P.2
McCabe, C.H.3
Cairns, R.4
Tonkin, A.M.5
Sacks, F.M.6
-
43
-
-
33645524176
-
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
-
Nissen S., Nicholls S.J., Sipahi I., Libby P., Raichlen J.S., Ballantyne C.M., et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
-
(2006)
JAMA
, vol.295
, pp. 1556-1565
-
-
Nissen, S.1
Nicholls, S.J.2
Sipahi, I.3
Libby, P.4
Raichlen, J.S.5
Ballantyne, C.M.6
-
44
-
-
33846414720
-
Task Force on Diabetes and Cardiovascular Disenses of the European Society of Cardiology (ESC); European Associatión for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summuty. The task force on Diabetes and Dardiovascular Diseases of the ESC and the EASD
-
Rydén L., Standl E., Bartnik M., Van der Berghe G., Betteridge J., De Boer M.J., et al. Task Force on Diabetes and Cardiovascular Disenses of the European Society of Cardiology (ESC); European Associatión for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes and cardiovascular diseases: executive summuty. The task force on Diabetes and Dardiovascular Diseases of the ESC and the EASD. Eur Heart J 28 (2007) 88-136
-
(2007)
Eur Heart J
, vol.28
, pp. 88-136
-
-
Rydén, L.1
Standl, E.2
Bartnik, M.3
Van der Berghe, G.4
Betteridge, J.5
De Boer, M.J.6
-
45
-
-
45149133036
-
Intensive Blood Gludose Control and Vascular Outcomes in Patients with Tipe 2 Diabetes
-
The ADVANCE Collaborative Group
-
The ADVANCE Collaborative Group. Intensive Blood Gludose Control and Vascular Outcomes in Patients with Tipe 2 Diabetes. N Engl J Med 358 (2008) 2560
-
(2008)
N Engl J Med
, vol.358
, pp. 2560
-
-
-
46
-
-
45149131667
-
Effects of Intensive Glucose Lowering in Type 2 Diabetes
-
The Action to Control Cardiovascular Risk in Diabetes Study Group
-
The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 358 (2008) 2545-2559
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
-
47
-
-
25144459980
-
The metabolic syndrome-a new worldwide definition
-
IDF Epidemiology Task Force Consensus Group
-
Alberti K., Zimmet P., Shaw J., and IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
-
(2005)
Lancet
, vol.366
, pp. 1059-1062
-
-
Alberti, K.1
Zimmet, P.2
Shaw, J.3
-
48
-
-
84921703567
-
-
Update Software, Oxford
-
Rees K., Bennett P., West R., Davey S.G., and Ebrahim S. Psychological Interventions for Coronary Heart Disease (Cochrane Review) (2004), Update Software, Oxford
-
(2004)
Psychological Interventions for Coronary Heart Disease (Cochrane Review)
-
-
Rees, K.1
Bennett, P.2
West, R.3
Davey, S.G.4
Ebrahim, S.5
-
49
-
-
0037022910
-
Inflammation and atherosclerosis
-
Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
-
(2002)
Circulation
, vol.105
, pp. 1135-1143
-
-
Libby, P.1
Ridker, P.M.2
Maseri, A.3
-
50
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker P., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.1
Hennekens, C.H.2
Buring, J.E.3
Rifai, N.4
-
51
-
-
10344265934
-
Risk of myocardial infarction and stroke after acute infection or vaccination
-
Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., and Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351 (2004) 2611-2618
-
(2004)
N Engl J Med
, vol.351
, pp. 2611-2618
-
-
Smeeth, L.1
Thomas, S.L.2
Hall, A.J.3
Hubbard, R.4
Farrington, P.5
Vallance, P.6
-
52
-
-
33645456050
-
Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture
-
Lowe G. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 133 (2006) 232-250
-
(2006)
Br J Haematol
, vol.133
, pp. 232-250
-
-
Lowe, G.1
-
53
-
-
1842587885
-
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
-
Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
-
(2004)
N Engl J Med
, vol.350
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.M.3
Eda, S.4
Eiriksdottir, G.5
Rumley, A.6
-
54
-
-
14544297938
-
Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans
-
Geelen A., Brouwer I.A., Schouten E.G., Maan A.C., Katan M.B., and Zock P.L. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81 (2005) 416-420
-
(2005)
Am J Clin Nutr
, vol.81
, pp. 416-420
-
-
Geelen, A.1
Brouwer, I.A.2
Schouten, E.G.3
Maan, A.C.4
Katan, M.B.5
Zock, P.L.6
-
55
-
-
0025167629
-
Parental history is an independent risk factor for coronary artery disease: the Framingham Study
-
Myers R., Kiely D.K., Cupples L.A., and Kannel W.B. Parental history is an independent risk factor for coronary artery disease: the Framingham Study. Am Heart J 120 (1990) 963-969
-
(1990)
Am Heart J
, vol.120
, pp. 963-969
-
-
Myers, R.1
Kiely, D.K.2
Cupples, L.A.3
Kannel, W.B.4
-
56
-
-
0015515790
-
Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives
-
Patterson D., and Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet 1 (1972) 393-399
-
(1972)
Lancet
, vol.1
, pp. 393-399
-
-
Patterson, D.1
Slack, J.2
-
57
-
-
20344376649
-
Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA
-
Holla O., Teie C., Berge K.E., and Leren T.P. Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA. Clin Chim Acta 356 (2005) 164-171
-
(2005)
Clin Chim Acta
, vol.356
, pp. 164-171
-
-
Holla, O.1
Teie, C.2
Berge, K.E.3
Leren, T.P.4
-
58
-
-
0035197537
-
Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis
-
Heath K., Gahan M., Whittall R.A., and Humphries S.E. Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolaemia: update, new features and mutation analysis. Atherosclerosis 154 (2001) 243-246
-
(2001)
Atherosclerosis
, vol.154
, pp. 243-246
-
-
Heath, K.1
Gahan, M.2
Whittall, R.A.3
Humphries, S.E.4
-
59
-
-
0035058910
-
A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom
-
Heath K., Humphries S.E., Middleton-Price H., and Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom. Eur J Hum Genet 9 (2001) 244-252
-
(2001)
Eur J Hum Genet
, vol.9
, pp. 244-252
-
-
Heath, K.1
Humphries, S.E.2
Middleton-Price, H.3
Boxer, M.4
-
61
-
-
0037154285
-
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study
-
Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105 (2002) 310-315
-
(2002)
Circulation
, vol.105
, pp. 310-315
-
-
Assmann, G.1
Cullen, P.2
Schulte, H.3
-
62
-
-
33646433424
-
Differential diagnosis of familial high density lipoprotein deficiency syndromes
-
Von Eckardstein A. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 186 (2006) 231-239
-
(2006)
Atherosclerosis
, vol.186
, pp. 231-239
-
-
Von Eckardstein, A.1
-
63
-
-
0032414773
-
Electrocardiogram-correlated image reconstruction from subsecond spiral computed tomography scans of the heart
-
Kachelriess M., and Kalender W.A. Electrocardiogram-correlated image reconstruction from subsecond spiral computed tomography scans of the heart. Med Phys 25 (1998) 2417-2431
-
(1998)
Med Phys
, vol.25
, pp. 2417-2431
-
-
Kachelriess, M.1
Kalender, W.A.2
-
64
-
-
26244459123
-
Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease
-
Tedeschi-Reiner E., Strozzi M., Skoric B., and Reiner Z. Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease. Am J Cardiol 96 (2005) 1107-1109
-
(2005)
Am J Cardiol
, vol.96
, pp. 1107-1109
-
-
Tedeschi-Reiner, E.1
Strozzi, M.2
Skoric, B.3
Reiner, Z.4
-
65
-
-
33645504844
-
Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology
-
Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I., et al. Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 27 (2006) 994-1005
-
(2006)
Eur Heart J
, vol.27
, pp. 994-1005
-
-
Stramba-Badiale, M.1
Fox, K.M.2
Priori, S.G.3
Collins, P.4
Daly, C.5
Graham, I.6
-
66
-
-
33846031473
-
Kidney-heart interactions: epidemiology, pathogenesis, and treatment
-
Berl T., and Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1 (2006) 8-18
-
(2006)
Clin J Am Soc Nephrol
, vol.1
, pp. 8-18
-
-
Berl, T.1
Henrich, W.2
-
67
-
-
1442334070
-
Predictors of new-onset kidney disease in a community-based population
-
Fox C., Larson M.G., Leip E.P., Culleton B., Wilson P.W.F., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
-
(2004)
JAMA
, vol.291
, pp. 844-850
-
-
Fox, C.1
Larson, M.G.2
Leip, E.P.3
Culleton, B.4
Wilson, P.W.F.5
Levy, D.6
-
68
-
-
33748934452
-
Cardiometabolic syndrome and chronic kidney disease: what is the link?
-
Sarafidis P., Whaley-Connell, Sowers J., and Bakris G.L. Cardiometabolic syndrome and chronic kidney disease: what is the link?. JCMS 1 (2006) 58-65
-
(2006)
JCMS
, vol.1
, pp. 58-65
-
-
Sarafidis, P.1
Whaley-Connell2
Sowers, J.3
Bakris, G.L.4
-
69
-
-
5644266226
-
The association among renal insufficiency, pharmacotherapy and outcomes in 6247 patients with heart failure and coronary artery disease
-
Ezekowitz J., McAlister F.A., Humphries K.H., Norris C.M., Tonelli M., Ghali W.A., et al. The association among renal insufficiency, pharmacotherapy and outcomes in 6247 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44 (2004) 1587-1592
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1587-1592
-
-
Ezekowitz, J.1
McAlister, F.A.2
Humphries, K.H.3
Norris, C.M.4
Tonelli, M.5
Ghali, W.A.6
-
70
-
-
0037065502
-
Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk people. BMJ 324 (2002) 71-86
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
71
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation
-
CURE Trial Investigators
-
CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 345 (2001) 494-502
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
-
72
-
-
20144373281
-
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
-
Sabatine M.S., Cannon C.P., Gibson C.M., Lopez-Sendon J.L., Montalescot G., Theroux P., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
-
(2005)
N Engl J Med
, vol.352
, pp. 1179-1189
-
-
Sabatine, M.S.1
Cannon, C.P.2
Gibson, C.M.3
Lopez-Sendon, J.L.4
Montalescot, G.5
Theroux, P.6
-
73
-
-
33645861080
-
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
-
The CHARISMA Investigators
-
Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., et al., The CHARISMA Investigators. Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events. N Engl J Med 354 (2006) 1-12
-
(2006)
N Engl J Med
, vol.354
, pp. 1-12
-
-
Bhatt, D.L.1
Fox, K.A.2
Hacke, W.3
Berger, P.B.4
Black, H.R.5
Boden, W.E.6
-
74
-
-
3242770664
-
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubleblind, placebo-controlled trial
-
Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, doubleblind, placebo-controlled trial. Lancet 364 (2004) 331-337
-
(2004)
Lancet
, vol.364
, pp. 331-337
-
-
Diener, H.C.1
Bogousslavsky, J.2
Brass, L.M.3
Cimminiello, C.4
Csiba, L.5
Kaste, M.6
-
75
-
-
0034763373
-
Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials
-
Sanmuganathan P.S., Ghahramani P., Jackson P.R., Wallis E.J., and Ramsay L.E. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 85 (2001) 265-271
-
(2001)
Heart
, vol.85
, pp. 265-271
-
-
Sanmuganathan, P.S.1
Ghahramani, P.2
Jackson, P.R.3
Wallis, E.J.4
Ramsay, L.E.5
-
76
-
-
0000093848
-
Betablokade after myocardial infarction: systematic review and meta regression analysis
-
Freemantle N., Cleland J., Young P., Mason J., and Harrison J. Betablokade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
-
(1999)
BMJ
, vol.318
, pp. 1730-1737
-
-
Freemantle, N.1
Cleland, J.2
Young, P.3
Mason, J.4
Harrison, J.5
-
77
-
-
0035799381
-
Beta-blokers in congestive Heart Failure. A Bayesian meta-analysis
-
Brophy J.M., Joseph L., and Rouleau J.L. Beta-blokers in congestive Heart Failure. A Bayesian meta-analysis. Ann Intern Med 134 (2001) 550-560
-
(2001)
Ann Intern Med
, vol.134
, pp. 550-560
-
-
Brophy, J.M.1
Joseph, L.2
Rouleau, J.L.3
-
78
-
-
0010838455
-
-
The ACE-inhibitor Myocardial Infarction Collaborative Group
-
Flather M.D., Yusuf Y., Kober L., Pfeffer M., Hall A., Murray G., et al., The ACE-inhibitor Myocardial Infarction Collaborative Group. Lancet 355 (2000) 1575-1581
-
(2000)
Lancet
, vol.355
, pp. 1575-1581
-
-
Flather, M.D.1
Yusuf, Y.2
Kober, L.3
Pfeffer, M.4
Hall, A.5
Murray, G.6
-
79
-
-
0032499670
-
Indication for ACE Inhibitors in the early treatment of acute myocardial infartion: systematic overview of individual data from 100.000 patients in randomized trials
-
ACE Inhibitor Myocardial Infartion Collaborative Group
-
ACE Inhibitor Myocardial Infartion Collaborative Group. Indication for ACE Inhibitors in the early treatment of acute myocardial infartion: systematic overview of individual data from 100.000 patients in randomized trials. Circulation 97 (1998) 2202-2212
-
(1998)
Circulation
, vol.97
, pp. 2202-2212
-
-
-
80
-
-
20444427156
-
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)
-
Schrader J., Luders S., Kulschewski A., Hammersen F., Plate K., Berger J., et al. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 36 (2005) 1218-1222
-
(2005)
Stroke
, vol.36
, pp. 1218-1222
-
-
Schrader, J.1
Luders, S.2
Kulschewski, A.3
Hammersen, F.4
Plate, K.5
Berger, J.6
-
81
-
-
7244227872
-
Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High Risk Acute Myocardial Infarction
-
Lee V.C., Rhew D.C., Dylan M., Badamgarav E., Braunstein G.D., and Weingarten S.R. Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High Risk Acute Myocardial Infarction. Ann Intern Med 141 (2004) 693-704
-
(2004)
Ann Intern Med
, vol.141
, pp. 693-704
-
-
Lee, V.C.1
Rhew, D.C.2
Dylan, M.3
Badamgarav, E.4
Braunstein, G.D.5
Weingarten, S.R.6
-
82
-
-
42049107348
-
Telmisartan, ramipril or both in patient ar high risk for vascular events
-
The ONTARGET Investigators
-
The ONTARGET Investigators. Telmisartan, ramipril or both in patient ar high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
-
(2008)
N Engl J Med
, vol.358
, pp. 1547-1559
-
-
-
83
-
-
33947517400
-
Por el comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento preventivo de la isquemia cerebral
-
Díez Tejedor E. (Ed), Prous Science, Barcelona
-
Diez Tejedor E., Fuentes B., Gil Núñez A.C., Gil Peralta A., and Matías Guiu J. Por el comité ad hoc del Grupo de Estudio de Enfermedades Cerebrovasculares de la SEN. Guía para el tratamiento preventivo de la isquemia cerebral. In: Díez Tejedor E. (Ed). Guía para el diagnostico y tratamiento del ictus (2006), Prous Science, Barcelona 133-183
-
(2006)
Guía para el diagnostico y tratamiento del ictus
, pp. 133-183
-
-
Diez Tejedor, E.1
Fuentes, B.2
Gil Núñez, A.C.3
Gil Peralta, A.4
Matías Guiu, J.5
-
84
-
-
67649462125
-
-
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention programmes: a comparison of EUROASPIRE I & II in 9 countries. EUROASPIRE I & II Group. European Action on Secondary prevention by Intervention to Reduce Events. Lancet. 2001;357:995-1001
-
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention programmes: a comparison of EUROASPIRE I & II in 9 countries. EUROASPIRE I & II Group. European Action on Secondary prevention by Intervention to Reduce Events. Lancet. 2001;357:995-1001.
-
-
-
-
85
-
-
61849116330
-
Cardiovascular Prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
-
The EUROASPIRE Study Group
-
Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U., and The EUROASPIRE Study Group. Cardiovascular Prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 373 (2009) 929-940
-
(2009)
Lancet
, vol.373
, pp. 929-940
-
-
Kotseva, K.1
Wood, D.2
De Backer, G.3
De Bacquer, D.4
Pyorala, K.5
Keil, U.6
-
86
-
-
44449132726
-
Determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular (estudio PREseAP)
-
Representación de los investigadores del estudio PREseAP
-
Orozco-Beltrán D., Brotons C., Moral I., Soriano N., Del Valle M.A., Rodríguez A.I., et al., Representación de los investigadores del estudio PREseAP. Determinantes del control de la presión arterial y los lípidos en pacientes con enfermedad cardiovascular (estudio PREseAP). Rev Esp Cardiol 61 (2008) 317-321
-
(2008)
Rev Esp Cardiol
, vol.61
, pp. 317-321
-
-
Orozco-Beltrán, D.1
Brotons, C.2
Moral, I.3
Soriano, N.4
Del Valle, M.A.5
Rodríguez, A.I.6
-
87
-
-
63149163469
-
Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC
-
Nombre el Proyecto Ictus del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología.
-
Gil-Núñez A., Vivancos J., Gabriel R., and Nombre el Proyecto Ictus del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Diagnóstico y prevención secundaria del infarto cerebral en España. Estudio DIAPRESIC. Med Clin (Barc) 131 (2008) 765-769
-
(2008)
Med Clin (Barc)
, vol.131
, pp. 765-769
-
-
Gil-Núñez, A.1
Vivancos, J.2
Gabriel, R.3
-
88
-
-
84961061763
-
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial
-
On behalf of EUROACTION Study Group
-
Wood D.A., Kotseva K., Connolly S., Jennings C., Mead A., Jones J., et al., On behalf of EUROACTION Study Group. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371 (2008) 1999-2012
-
(2008)
Lancet
, vol.371
, pp. 1999-2012
-
-
Wood, D.A.1
Kotseva, K.2
Connolly, S.3
Jennings, C.4
Mead, A.5
Jones, J.6
|